Body
Document
Sections
Reading
FDA
21 CFR Parts 210 & 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals: FDA Baseline CGMP Regulations: Organization, Facilities, Production Controls, Laboratory, and Records
FDA-21CFR-211-Complete · Regulations and guidance for industry · 4,112 words · added 11 Jun 2026
7
18 min
FDA
21 CFR Part 820 — Quality Management System Regulation (QMSR): FDA Quality System Requirements for Medical Device Manufacturers — 2024 QMSR Final Rule Aligned with ISO 13485:2016
FDA-21CFR-820-Complete · Regulations and guidance for industry · 5,018 words · added 11 Jun 2026
20
22 min
FDA
21 CFR Subchapter F — Biologics (Parts 600–680): FDA Regulatory Framework for Biological Products: Licensing, Manufacturing Standards, and Lot Release Requirements
FDA-21CFR-Biologics-Complete · Regulations and guidance for industry · 3,968 words · added 11 Jun 2026
—
17 min
FDA
21 CFR Part 11 — Electronic Records; Electronic Signatures: FDA Requirements for Electronic Records and Electronic Signatures in Regulated Industries
FDA-21CFR-Part11-Complete · Regulations and guidance for industry · 5,202 words · added 11 Jun 2026
—
23 min
FDA
21 CFR Part 312 — Investigational New Drug Applications (IND): FDA Requirements for Investigational New Drug Applications: Sponsor Obligations, CMC Requirements, and CDMO Manufacturing Responsibilities
FDA-21CFR-Part312-Complete · Regulations and guidance for industry · 1,219 words · added 11 Jun 2026
6
5 min
FDA
21 CFR Part 4 — Regulation of Combination Products: FDA Jurisdiction Assignment, PMOA Determination, and CGMP Dual Compliance for Combination Products
FDA-21CFR-Part4-Complete · Regulations and guidance for industry · 2,761 words · added 11 Jun 2026
10
12 min
FDA
FDA Guidance for Industry: Sterile Drug Products by Aseptic Processing — CGMP (2004)
FDA-Aseptic-Complete · Regulations and guidance for industry · 10,842 words · added 11 Jun 2026
4
47 min
FDA
FDA Guidance for Industry: Container and Closure System Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile Products (2008)
FDA-CCIT-Complete · Regulations and guidance for industry · 3,004 words · added 11 Jun 2026
—
13 min
FDA
FDA Guidance: Current Good Manufacturing Practice Requirements for Combination Products (Jan 2017): Current Good Manufacturing Practice Requirements for Combination Products
FDA-ComboProd-CGMP-Complete · Regulations and guidance for industry · 25,822 words · added 11 Jun 2026
—
112 min
FDA
FDA Draft Guidance: Human Factors Studies in Combination Product Design and Development (Feb 2016): Human Factors Studies and Related Clinical Study Considerations in Combination Product Design and Development
FDA-ComboProd-HF-Complete · Regulations and guidance for industry · 9,352 words · added 11 Jun 2026
2
41 min
FDA
FDA Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics — CMC Documentation (1999)
FDA-ContainerClosure-Complete · Regulations and guidance for industry · 16,834 words · added 11 Jun 2026
—
73 min
FDA
FDA Guidance for Industry: Container Closure System and Component Changes: Glass Vials and Stoppers (2024)
FDA-GlassVial-Complete · Regulations and guidance for industry · 8,026 words · added 11 Jun 2026
7
35 min
FDA
FDA Guidance for Industry: Submission of Documentation for Parametric Release of Drug Products Terminally Sterilized by Moist Heat (2010)
FDA-ParametricRelease-Complete · Regulations and guidance for industry · 3,026 words · added 11 Jun 2026
—
13 min
FDA
FDA Compliance Program Guidance Manual 7356.002A: Sterile Drug Process Inspections (2015): Sterile Drug Process Inspections — FDA CPGM 7356.002A
FDA-ProcessInspection-Complete · Regulations and guidance for industry · 18,851 words · added 11 Jun 2026
—
82 min
FDA
FDA Guidance for Industry: Process Validation: General Principles and Practices (January 2011)
FDA-ProcessVal-Complete · Regulations and guidance for industry · 7,713 words · added 11 Jun 2026
—
34 min